
Senior Machine Learning Engineer, Small Molecule Drug Discovery, AI for Drug Discovery
Genentech4 days ago
Base Salary
$168k - $312k/yr
Responsibilities
- Develop computational methods, reusable libraries, APIs, and services for small-molecule drug discovery.
- Build workflows spanning cheminformatics, molecular modeling, and property prediction.
- Partner with medicinal and computational chemists to identify bottlenecks and validate solutions in drug discovery campaigns.
- Own capabilities from prototype through deployment and ongoing use on cloud and HPC infrastructure.
- Shape technical direction, improve software quality, and contribute through publications, open-source tools, and conference presentations.
Requirements
- PhD with 0–3 years of relevant experience, or BS/MS with 5+ years of relevant industry experience, in computer science, software engineering, computational chemistry, chemical engineering, or a related quantitative or scientific field.
- Strong Python programming and software engineering skills, including design, debugging, performance optimization, code review, automated testing, packaging, documentation, and continuous integration.
- Experience developing cheminformatics or computational chemistry workflows with RDKit, OpenEye, or comparable libraries.
- Understanding of foundational machine learning concepts and experience integrating, deploying, and troubleshooting trained models built with modern ML frameworks.
- Strong experience with agent-assisted software development using tools such as Codex or Claude Code, including reviewing, testing, and maintaining generated code.
- Evidence of impactful technical or scientific contributions through software, open-source work, publications, or substantial projects.
- Preferred: experience with Linux, Docker, AWS, and Kubernetes for deploying, monitoring, and troubleshooting scientific software workloads.
Benefits
- Benefits are provided through the employer’s benefits program.
- Relocation benefits are not available for this job posting.
Tech Stack
Categories
About Genentech
Genentech discovers, develops, and commercializes biologic therapies for serious diseases across oncology, immunology, neuroscience, ophthalmology, infectious disease, and metabolism. Founded in 1976 and headquartered in South San Francisco, it operates as a member of the Roche Group, with research centered in its gRED organization and revenue driven by prescription drug sales and collaborations.